Pulmonary hypertension alters soluble guanylate cyclase activity and expression in pulmonary arteries isolated from fetal lambs (Q31950468)

5 July 2017

Pulmonary hypertension alters soluble guanylate cyclase activity and expression in pulmonary arteries isolated from fetal lambs (English)

1 reference

5 July 2017

pulmonary hypertension

1 reference

Tzao C

1

1 reference

5 July 2017

Nickerson PA

2

1 reference

5 July 2017

Russell JA

3

1 reference

5 July 2017

Gugino SF

4

1 reference

5 July 2017

Steinhorn RH

5

1 reference

5 July 2017

1 February 2001

1 reference

5 July 2017

Pediatric Pulmonology

1 reference

5 July 2017

31

1 reference

5 July 2017

2

1 reference

5 July 2017

97-105

1 reference

Ligating the ductus arteriosus before birth causes persistent pulmonary hypertension in the newborn lamb.

5 July 2017

1 reference

https://api.crossref.org/works/10.1002%2F1099-0496%28200102%2931%3A2%3C97%3A%3AAID-PPUL1016%3E3.0.CO%3B2-K

Failure of postnatal adaptation of the pulmonary circulation after chronic intrauterine pulmonary hypertension in fetal lambs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-0496%28200102%2931%3A2%3C97%3A%3AAID-PPUL1016%3E3.0.CO%3B2-K

Coordinated regulation of genes of the nitric oxide and endothelin pathways during the development of pulmonary hypertension in fetal lambs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-0496%28200102%2931%3A2%3C97%3A%3AAID-PPUL1016%3E3.0.CO%3B2-K

Chronic nitric oxide inhibition in utero produces persistent pulmonary hypertension in newborn lambs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-0496%28200102%2931%3A2%3C97%3A%3AAID-PPUL1016%3E3.0.CO%3B2-K

Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-0496%28200102%2931%3A2%3C97%3A%3AAID-PPUL1016%3E3.0.CO%3B2-K

Pulmonary and systemic effects of the phosphodiesterase inhibitor dipyridamole in newborn lambs with persistent pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-0496%28200102%2931%3A2%3C97%3A%3AAID-PPUL1016%3E3.0.CO%3B2-K

The cGMP-specific phosphodiesterase inhibitor E4021 dilates the pulmonary circulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-0496%28200102%2931%3A2%3C97%3A%3AAID-PPUL1016%3E3.0.CO%3B2-K

Heterogeneous distribution of soluble guanylate cyclase in the pulmonary vasculature of the fetal lamb.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-0496%28200102%2931%3A2%3C97%3A%3AAID-PPUL1016%3E3.0.CO%3B2-K

Endothelium-dependent relaxation and cyclic GMP accumulation in rabbit pulmonary artery are selectively impaired by moderate hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-0496%28200102%2931%3A2%3C97%3A%3AAID-PPUL1016%3E3.0.CO%3B2-K

Immunoaffinity purification of soluble guanylyl cyclase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-0496%28200102%2931%3A2%3C97%3A%3AAID-PPUL1016%3E3.0.CO%3B2-K

Purification of soluble guanylyl cyclase from bovine lung by a new immunoaffinity chromatographic method

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-0496%28200102%2931%3A2%3C97%3A%3AAID-PPUL1016%3E3.0.CO%3B2-K

Persistent pulmonary hypertension of the newborn in the era before nitric oxide: practice variation and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-0496%28200102%2931%3A2%3C97%3A%3AAID-PPUL1016%3E3.0.CO%3B2-K

Colliquation therapy of myoadenomatous prostatic hyperplasia (author's transl)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-0496%28200102%2931%3A2%3C97%3A%3AAID-PPUL1016%3E3.0.CO%3B2-K

Effects of long-term nitroglycerin treatment on endothelial nitric oxide synthase (NOS III) gene expression, NOS III-mediated superoxide production, and vascular NO bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-0496%28200102%2931%3A2%3C97%3A%3AAID-PPUL1016%3E3.0.CO%3B2-K

The cGMP phosphodiesterase inhibitor zaprinast enhances the effect of nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-0496%28200102%2931%3A2%3C97%3A%3AAID-PPUL1016%3E3.0.CO%3B2-K

10.1002/1099-0496(200102)31:2<97::AID-PPUL1016>3.0.CO;2-K

21 January 2018

Identifiers

DOI

1 reference

5 July 2017

1 reference